Hyderabad, India
Albany Molecular has initiated the first major expansion of its Hyderabad Research Centre in India with the construction of a 50,000-sf R&D center. Slated for completion in late 2007, the facility will house early stage contract drug discovery research, including medicinal chemistry and custom chemical synthesis. The project will include a scale-up production laboratory for active pharmaceutical ingredients and intermediates. The new building will accommodate over 100 employees in addition to the 40-employee capacity at the existing facility on the site.
